miRNA |
Drug Name |
CID |
NSC |
FDA |
Effect/Pattern |
Detection Method |
Level |
Phenotype |
Condition |
hsa-mir-452 |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Gastric Cancer |
cell line (BGC823) |
hsa-mir-452 |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (A2780CP20) |
hsa-mir-452 |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (CP20) |
hsa-mir-452 |
Ceritinib |
57379345 |
NSC776422 |
approved |
sensitive |
|
|
|
cell line (H3122) |
hsa-mir-452 |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (BGC-823) |
hsa-miR-452-5p |
(11r,15s,17s)-17-methyl-14,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3,5,7-tetraene-2,9-dione |
54611663 |
NSC722392 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
(2e)-2-hydroxyimino-4-(3-methyl-4-oxido-1-oxoquinoxalin-1-ium-2-yl)-4-oxo-n-(2,4,5-trichlorophenyl)butanamide |
6399319 |
NSC635544 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
(2Z,6Z)-2,6-bis[[3-[(dimethylamino)methyl]-4-hydroxyphenyl]methylidene]cyclohexan-1-one |
6067712 |
NSC683834 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(3e)-3-[(2-chloro-1-phenylindol-3-yl)methylidene]-5-methoxy-6-methyl-1h-indol-2-one |
5471471 |
NSC711611 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(3e)-5-methoxy-3-[(6-phenyl-2,3-dihydroimidazo[2,1-b][1,3]thiazol-5-yl)methylidene]-1h-indol-2-one |
5471411 |
NSC711066 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(4aR,9aR)-9-(4-methylphenyl)sulfonyl-3,4,4a,9a-tetrahydrocarbazole |
372866 |
NSC648556 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(4e)-4-(3h-1,3-benzothiazol-2-ylidene)-1-[4-(difluoromethylsulfanyl)phenyl]-5-iminopyrrolidin-2-one |
135543874 |
NSC744116 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(4e)-4-(3h-1,3-benzothiazol-2-ylidene)-5-imino-1-(3-methoxyphenyl)pyrrolidin-2-one |
135892287 |
NSC744115 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(4S,9aR)-4-(4-fluoroanilino)-9-(4-hydroxy-3,5-dimethoxyphenyl)-6,7-dimethoxy-3a,4,9,9a-tetrahydro-3H-benzo[f][2]benzofuran-1-one |
369962 |
NSC642329 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(4z)-n-[(2-chlorobenzylidene)amino]-4-(dimethylaminohydrazono)-5-methyl-pyrazole-3-carboxamide |
135545659 |
NSC131257 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(5s,8ar)-5-[(1-benzylpiperidin-4-yl)amino]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5h-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one;hydrochloride |
374331 |
NSC651855 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(8e)-2-amino-4-(3,4-dimethoxyphenyl)-8-[(3,4-dimethoxyphenyl)methylidene]-5-methyl-6,7-dihydro-5h-quinoline-3-carbonitrile |
|
NSC690754 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(8R,9S,10R,13S,14S,16E)-10,13-dimethyl-16-[[3-(2-morpholin-4-ylethoxy)phenyl]methylidene]-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,17-dione |
24205793 |
NSC736753 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(e)-1-(benzenesulfonyl)-3-(2-phenyl-1h-indol-3-yl)prop-2-en-1-one |
54613416 |
NSC749193 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(E)-1-[4-(quinazolin-4-ylamino)phenyl]-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one |
155816064 |
NSC760015 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(E)-2-(3,4-dihydroxybenzoyl)-3-(1H-indol-3-yl)prop-2-enenitrile |
5329275 |
NSC650934 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
(Z)-[5-(4-carboxy-N-methylanilino)-2,4-dinitrophenoxy]imino-(dimethylamino)-oxidoazanium |
11154356 |
NSC731703 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
[(1r,2r,3ar,4s,5s,6e,9s,10r,11s,13r,13as)-2,4,13-triacetyloxy-1-benzoyloxy-3a,10-dihydroxy-2,5,8,8-tetramethyl-12-methylidene-11-(2-methylpropoxy)-3,4,5,9,10,11,13,13a-octahydro-1h-cyclopenta[12]annul |
5469445 |
NSC688235 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
[(1r,2r,3r,4r,6r,8s,9e,12s,13s,14r,15s)-3,4,6,12,13-pentaacetyloxy-4,8,11,11-tetramethyl-14-(2-methylpropoxy)-7,18-dioxo-19-oxatricyclo[13.4.0.02,6]nonadec-9-en-15-yl] benzoate |
5469441 |
NSC688228 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
[(1R,2S,10S,13S,14R)-7-(4-fluorophenyl)-10,14-dimethyl-6,7,9-triazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-4(8),5,19-trien-17-yl] acetate |
392371 |
NSC692655 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
[(1S,16E,24E,26E,28Z)-1-hydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-18-yl] 3-(diethylamino)propanoate; |
5386305 |
NSC606699 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
[(3s,8r,10r,13s,17e)-10,13-dimethyl-17-(phenylcarbamoyloxyimino)-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] n-phenylcarbamate |
9569960 |
NSC629229 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
[(3s,8r,9s,10r,13s,14s,16e,17e)-16-[(3,4-dimethoxyphenyl)methylidene]-17-hydroxyimino-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate |
9572442 |
NSC716258 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
[2-(12,14-dioxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-3-yl)-3-hydroxy-6-(hydroxymethyl)-5-methoxyoxan-4-yl] 2,6-diaminohexanoate;hydrochloride |
24203046 |
NSC726578 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
1'-hydroxy-2'-(naphthalene-1-carbonyl)-1'-naphthalen-1-ylspiro[1,3-dihydro-1-benzazepine-4,4'-cyclohexane]-2,5-dione |
|
NSC682763 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
1-(1-naphthylmethylene)-4-(1-naphthyl)semicarbazide |
5859414 |
NSC680931 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
11-(4-nitrophenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one |
54608965 |
NSC697748 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
13-methoxy-6-methyl-2-nitro-6,9,17-triazatetracyclo[8.7.1.05,18.011,16]octadeca-1,3,5(18),10,12,14,16-heptaene |
438699 |
NSC658995 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
1h-benzimidazole, 5,5'-dithiobis[2-(trifluoromethyl)- (9ci) |
|
NSC659162 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
2-((5-methyl-3-isoxazolyl)amino)-4-((5-methyl-3-isoxazolyl)imino)-1(4h)-naphthalenone |
373420 |
NSC649750 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
2-(1-hydroxyethyl)thieno[3,2-f][1]benzothiole-4,8-dione |
391375 |
NSC690432 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
2-(2-amino-6-phenylpyrimidin-4-yl)-4-methylphenol |
386504 |
NSC678879 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
2-[(e)-[6-(3,6-dimethoxy-2-nitrophenyl)-2-propylimidazo[2,1-b][1,3]thiazol-5-yl]methylideneamino]guanidine;hydrochloride |
9572654 |
NSC723548 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
2-[[(1s,5s,8z,12s,20s)-13-phenoxycarbonyl-21-oxa-13-azapentacyclo[10.9.0.01,20.05,20.014,19]henicosa-8,14,16,18-tetraen-6,10-diyn-5-yl]oxy]acetic acid |
54604782 |
NSC677586 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
2-[[(3s,8s,9s,10r,11s,13s,14s,16s,17r)-3,11-dihydroxy-17-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-16-yl]oxy]-6-methy |
392623 |
NSC693185 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
2-[4-[5-(3,4-dimethoxyphenyl)imidazol-1-yl]phenyl]-5,7-dimethoxy-1,3-benzothiazole |
60147635 |
NSC751902 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
2-acetyl-1,2-dihydroellipticine |
376328 |
NSC657149 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
2,3-dehydrosarcovagine d |
54612860 |
NSC748913 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
2,3-dimethoxyindolo[2,1-a]isoquinolin-7-ium-12-one |
498408 |
NSC627787 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
2,3,5-triphenyl-1,3-selenazol-3-ium-4-olate |
363056 |
NSC627605 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
2,5,11-trimethyl-9-phenoxy-6h-pyrido[4,3-b]carbazol-2-ium;acetate |
10431819 |
NSC650269 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
2,7-bis(methoxycarbonylmethyl)-10-methylphenothiazine |
384444 |
NSC674225 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
3-(3,5-dibromo-4-methoxyphenyl)-2-(3-pyridinyl)acrylonitrile |
5467796 |
NSC659319 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
3-(3,5-dichlorophenyl)-2-(2-pyridinyl)acrylonitrile |
5467799 |
NSC659323 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
3-(4-methoxyphenyl)-4-methyl-8-pyrrolidin-1-yl-8H-thieno[2,3-b]pyrrolizin-4-ium;iodide |
388538 |
NSC683518 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
3-(4-methoxyphenyl)-5,5,5-triphenyl-4,5-dihydro-1,2,5lambda(5)-oxazaphosphole |
|
NSC304610 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
3-(benzenesulfonyl)-7-benzyl-2-methoxy-5,6-dihydropyrazolo[3,4-h]quinoline |
54613023 |
NSC750762 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
3-[(2,3-dimethoxyphenyl)methyl]-7,8-dimethoxy-5-methylsulfanyl-2,5-dihydro-1H-3-benzazepin-4-one |
359177 |
NSC619859 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
3-[2-(1h-indol-3-yl)-2-oxoethyl]quinoxalin-2(1h)-one |
400273 |
NSC711806 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
3-bromo-4-(2-(4-methoxyphenyl)ethynyl)furan-2(5h)-one |
24204187 |
NSC730944 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
3,5-dichloro-N-[4-[3-(3-chloro-4-methoxyphenyl)-4-pyridin-4-ylpyrazol-1-yl]phenyl]benzamide |
142712058 |
NSC755465 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4-(2-(((6-bromo-1,3-benzodioxol-5-yl)methyl)amino)ethyl)phenol |
290548 |
NSC154572 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4-(4-carbazol-9-ylbutanoylamino)-n-[5-[3-(dimethylamino)propylcarbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide |
406397 |
NSC724462 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4-(4-chlorophenyl)-N-(2-methoxyphenyl)-3-prop-2-enyl-1,3-thiazol-2-imine;hydrobromide |
396119 |
NSC701666 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4-[(1-benzyl-4-chloro-2,5-dioxopyrrol-3-yl)amino]-N-(4-fluorophenyl)benzamide |
1194957 |
NSC732830 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4-[(2z)-2-(5-oxooxolan-2-ylidene)ethoxy]chromen-2-one |
24205379 |
NSC735331 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
4-[(4z)-5-oxo-4-[(4-phenoxyphenyl)methylidene]-2-phenylimidazol-1-yl]-n-(1,3-thiazol-2-yl)benzenesulfonamide |
5472414 |
NSC718649 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4-[2-(5,6-dihydrobenzo[a]carbazol-11-yl)ethyl]morpholine |
390894 |
NSC689069 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4-[4-(3-methoxyphenyl)piperazin-1-yl]-5H-pyrrolo[3,2-d]pyrimidine |
155815900 |
NSC754824 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4-acetylspiro[1,3,5,6,7,8-hexahydrocyclopenta[b]naphthalene-2,2'-3,6,7,8-tetrahydro-1h-cyclopenta[g]naphthalene]-5'-one |
382750 |
NSC670428 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4-benzyl-1-(2-chlorophenyl)-[1,2,4]triazolo[4,3-a]quinoxaline |
46945878 |
NSC761676 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4-nitro-n-[(7s)-1,2,3-trihydroxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5h-benzo[a]heptalen-7-yl]benzamide |
391582 |
NSC691037 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4,4-diphenyl-2-(3,4,5-trimethoxyphenyl)-1,3-diazinane;hydrochloride |
379863 |
NSC665001 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4,5-bis(4-methoxyphenyl)-1h-imidazol-2(5h)-one |
231112 |
NSC26692 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
4,5,15,16-tetraphenyl-10-(2,4,6-triphenylpyridin-1-ium-1-yl)-3,6,14,17-tetraoxa-23-azatricyclo[17.3.1.18,12]tetracosa-1(23),8(24),9,11,19,21-hexaen-24-olate |
16129807 |
NSC674178 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
5-(4-chlorophenyl)-n-(3,4,5-trimethoxyphenyl)-1h-pyrazol-4-amine |
45028878 |
NSC744683 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
5-[(E)-2-(5-ethyl-1-methylpyridin-1-ium-2-yl)ethenyl]quinolin-8-ol;iodide |
135534376 |
NSC79543 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
5-[2-(2,5-dimethoxyphenyl)ethynyl]-N-[2-(4-fluorophenyl)ethyl]-2-methoxybenzamide |
403660 |
NSC718728 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
5-[2-(2,5-dimethoxyphenyl)ethynyl]-N-hexyl-2-methoxybenzamide |
403659 |
NSC718727 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
5-[3-[(7-chloroquinolin-4-yl)amino]phenyl]-3-(3,4,5-trimethoxyphenyl)-3,4-dihydropyrazole-2-carbaldehyde |
72374830 |
NSC762542 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
5-fluoro-N-(2-methyl-3-oxo-8-phenyl-1-thia-4-azaspiro[4.5]decan-4-yl)-3-phenyl-1H-indole-2-carboxamide |
24205446 |
NSC735540 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
5,11-dimethyl-1h-benzo[a]carbazole-1,4(11h)-dione |
372651 |
NSC648148 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
6-hydroxy-3,3,11,12-tetramethyl-pyrano[2,3-c]acridin-7-one |
5465763 |
NSC660813 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
8-(2,3-dimethoxyphenyl)-7-methyl-n-phenyl-7,8-dihydro-6h-[1,3]dioxolo[4,5-g]chromen-6-amine |
381363 |
NSC667903 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
8-chloro-3-(naphthalen-1-ylamino)-5,5-dioxo-[1,2,4]triazolo[4,3-b][1,4,2]benzodithiazine-7-carbonitrile |
406667 |
NSC724907 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
8-hydroxymanzamine a |
5468481 |
NSC670852 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Abiraterone |
132971 |
NSC749226 |
approved |
sensitive |
|
|
|
|
hsa-miR-452-5p |
Aminopyrimidine-f |
406276 |
NSC724328 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Ammonium trichlorotellurate |
|
NSC618654 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Austocystin d |
5470400 |
NSC700893 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
Azure b bromide |
13797451 |
NSC16166 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
Blastmycin |
245869 |
NSC58239 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
C8, carbonyl prodigiosine |
135540857 |
NSC742417 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Dimethyl 2,2'-(pyridine-2,6-diyldicarbonyl)bis(1-methylhydrazinecarbodithioate) |
375401 |
NSC655072 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Dromostanolone propionate |
224004 |
NSC12198 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Ethyl 2-[(2e)-2-[(4-chlorophenyl)methylidene]hydrazinyl]-5-phenyl-1h-pyrrole-3-carboxylate |
45027953 |
NSC740252 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Gsk718429a |
44587530 |
NSC756188 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Hexyl (e)-3-[(2s,4z)-2-(hydroxymethyl)-4-(4-methyl-3-propan-2-ylpentylidene)-5-oxooxolan-2-yl]prop-2-enoate |
5471817 |
NSC714070 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Hopeaphenol |
495605 |
NSC661748 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
Hydrazine sulfate |
24842 |
NSC150014 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Iejimalide a. |
5473233 |
NSC724579 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Indoline, 5-chloro-1,3,3-trimethyl-2-methylene- (8ci) |
81308 |
NSC158263 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Isatin dr |
24204246 |
NSC731093 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Itraconazole |
55283 |
NSC754771 |
approved |
sensitive |
|
|
|
|
hsa-miR-452-5p |
J-400634 |
385621 |
NSC676944 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Kipca |
4055 |
NSC4170 |
approved |
resistant |
|
|
|
|
hsa-miR-452-5p |
L-lys-l-p-no2phe-l-ala-l-p-no2phenh2 |
386384 |
NSC678355 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Ls-133613 |
365597 |
NSC633398 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Ls-41225 |
57787 |
NSC664951 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Ls-58067 |
379524 |
NSC664181 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Ls-59969 |
380292 |
NSC665773 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Mauve |
407617 |
NSC7801 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Methyl (2R,11bS)-2-[[(3R)-3-ethyl-1,4-dioxaspiro[4.5]decan-3-yl]methyl]-3-sulfanylidene-2,5,6,11-tetrahydro-1H-indolizino[8,7-b]indole-11b-carboxylate |
386808 |
NSC679516 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
N'-butyl-4-[2-[2-[4-(N'-butylcarbamimidoyl)phenoxy]ethylsulfanyl]ethoxy]benzenecarboximidamide;hydrochloride |
54613223 |
NSC750501 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
N-(4-((4-anilino-1-benzyl-4-piperidinyl)ethynyl)-1-benzyl-4-piperidinyl)-n-phenylamine |
379997 |
NSC665299 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
N-[(3S,10S,13S,17S)-17-[1-(dimethylamino)ethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]formamide |
54612852 |
NSC748904 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
N-[(e)-[2-chloro-4-(dimethylamino)phenyl]methylideneamino]naphthalene-1-carboxamide |
9568495 |
NSC115980 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
N-[(e)-[6-(2,5-dimethylanilino)-1-(4-hydroxyphenyl)-2-methyl-1,6-dioxohexan-3-ylidene]amino]-2-hydroxynaphthalene-1-carboxamide |
9555801 |
NSC630357 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
N-[2-(3,4-dihydroxyphenyl)ethyl]-3-phenylpropanamide |
383148 |
NSC671189 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
N-[2-(4-acetylpiperazin-1-yl)ethyl]-3-(3-chloro-5-hydroxyphenyl)-4-pyridin-4-ylpyrazole-1-carboxamide |
53483672 |
NSC753193 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-(4-pyridin-2-ylpiperazin-1-yl)acetamide |
24206025 |
NSC737733 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
N-[6'-(diethylamino)-3-oxospiro[2-benzofuran-1,9'-xanthene]-2'-yl]-N-phenylacetamide |
389678 |
NSC686130 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
N,n-bis(2-chloroethyl)-4-(6-chloropurin-9-yl)aniline |
254234 |
NSC78298 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
NSC605607 |
|
NSC605607 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Pc 287 |
239486 |
NSC44580 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Pectenotoxin ii |
5468320 |
NSC668555 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Platinum, (1,2-cyclohexanediamine-n,n')(propanedioato(2-)-o,o')-, (sp-4-2-(1r-trans))- (9ci) |
|
NSC266047 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Propyl gallate |
4947 |
NSC2626 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
Protein: pahiv4 |
|
NSC678525 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Psoralen quinone |
68083 |
NSC401268 |
|
resistant |
|
|
|
|
hsa-miR-452-5p |
Spiro[s-indacene-2(5h),2'-[2h]inden]-5-one, 1,1',3,3',6,7-hexahydro- |
382726 |
NSC670404 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Stk673166 |
|
NSC717468 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Vancide 26 |
79411 |
NSC5337 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Ver a |
5351232 |
NSC126728 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Z198955462 |
135528004 |
NSC744178 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Z28714792 |
2671841 |
NSC746248 |
|
sensitive |
|
|
|
|
hsa-miR-452-5p |
Temozolomide |
5394 |
NSC362856 |
approved |
resistant |
|
High |
Glioblastoma |
cell line (U251MG, U251R, U87MG, M059K, M059J) |
hsa-miR-452-5p |
10-Hydroxycamptothecin |
97226 |
NSC107124 |
|
resistant |
|
High |
Gastric Cancer |
cell line (BGC823, SGC-7901, MGC-803, HGC-27, NCI-N87, AGS) |
hsa-miR-452-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
resistant |
|
High |
Cholangiocarcinoma |
cell line (HuCCT1, HuH28) |
hsa-miR-452-5p |
Docetaxel |
148124 |
NSC628503 |
approved |
resistant |
|
Low |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-452-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (C13*, A2780, OV2008) |
hsa-miR-452-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
sensitive |
|
High |
Gastric Cancer |
cell line (BGC823, HGC-27, NCI-N87) |
hsa-miR-452-5p |
Doxorubicin |
31703 |
NSC123127 |
approved |
sensitive |
|
Low |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-452-5p |
Docetaxel |
148124 |
NSC628503 |
approved |
sensitive |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-452-5p |
Doxorubicin |
31703 |
NSC123127 |
approved |
sensitive |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-452-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
resistant |
|
High |
Pancreatic Cancer |
cell line (SW1990) |
hsa-miR-452-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
sensitive |
|
High |
Pancreatic Cancer |
cell line (SW1990) |
hsa-miR-452-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
High |
Non-Small Cell Lung Cancer |
cell line (A549) |
hsa-miR-452-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
High |
Small Cell Lung Cancer |
cell line (H446) |
hsa-miR-452-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
High |
Ovarian Cancer |
tissue |
hsa-miR-452-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Gallbladder Cancer |
cell line (GBC-SD, NOZ) |
hsa-miR-452-5p |
Gefitinib |
123631 |
NSC715055 |
approved |
sensitive |
|
High |
Non-Small Cell Lung Cancer |
cell line (HCC827) |
hsa-miR-452-5p |
Methotrexate |
126941 |
NSC740 |
approved |
sensitive |
|
High |
Colorectal Cancer |
cell line (LS174T) |
hsa-miR-452-5p |
Sunitinib |
5329102 |
NSC750690 |
approved |
sensitive |
|
High |
Renal Cell Cancer |
tissue |
hsa-miR-452-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
sensitive |
|
High |
Pancreatic Cancer |
cell line (AsPC-1) |
hsa-miR-452-5p |
Bromocriptine |
31101 |
NSC169774 |
approved |
resistant |
|
High |
Prolactinoma |
tissue |
hsa-miR-452-5p |
Fluorouracil |
3385 |
NSC19893 |
approved |
sensitive |
|
High |
Colorectal Cancer |
cell line (HCT-116) |
hsa-miR-452-5p |
Methotrexate |
126941 |
NSC740 |
approved |
sensitive |
|
High |
Colorectal Adenocarcinoma |
cell line (HT-29) |
hsa-miR-452-5p |
Temozolomide |
5394 |
NSC362856 |
approved |
resistant |
|
High |
Glioblastoma |
cell line (A172) |
hsa-miR-452-5p |
Temozolomide |
5394 |
NSC362856 |
approved |
resistant |
|
|
|
cell line (U251) |
hsa-miR-452-5p |
Gefitinib |
123631 |
NSC715055 |
approved |
resistant |
|
|
|
cell line (PC9) |
hsa-miR-452-5p |
Osimertinib |
71496458 |
NSC779217 |
approved |
resistant |
|
|
|
cell line (PC9) |
hsa-miR-452-5p |
Fluorouracil |
3385 |
NSC19893 |
approved |
sensitive |
|
|
|
cell line (HCT116) |
hsa-miR-452-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
|
|
cell line (SKVO3ip1) |
hsa-miR-452-5p |
Doxorubicin |
31703 |
NSC123127 |
approved |
resistant |
|
|
|
cell line (HS578T) |
hsa-miR-452-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (A549) |
hsa-miR-452-5p |
Exemestane |
60198 |
NSC713563 |
approved |
sensitive |
|
|
|
cell line (MCF-7) |
hsa-miR-452-5p |
Osimertinib |
71496458 |
NSC779217 |
approved |
sensitive |
|
|
|
cell line (H1975) |
hsa-miR-452-5p |
Fluorouracil |
3385 |
NSC19893 |
approved |
sensitive |
|
|
|
cell line (HCT15) |
hsa-miR-452-5p |
4-Hydroxytamoxifen+Tamoxifen |
|
|
|
resistant |
|
|
|
cell line (LY2) |
hsa-miR-452-5p |
Methotrexate |
126941 |
NSC740 |
approved |
sensitive |
|
|
|
cell line (HT29) |
hsa-miR-452-5p |
Fluorouracil |
3385 |
NSC19893 |
approved |
resistant |
|
|
|
cell line (KM12C) (72 h) |
hsa-miR-452-5p |
Sunitinib |
5329102 |
NSC750690 |
approved |
resistant |
|
|
|
tissue (CardA) |
hsa-miR-452-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
resistant |
|
|
|
cell line (HuH28) |
hsa-miR-452-5p |
Oxaliplatin |
6857599 |
NSC266046 |
approved |
resistant |
|
|
|
cell line (IGROV-1) |
hsa-miR-452-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (IGROV-1) |
hsa-miR-452-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
sensitive |
|
|
|
cell line (PC3PR70) |
hsa-miR-452-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (A549) |
hsa-miR-452-5p |
Ceritinib |
57379345 |
NSC776422 |
approved |
sensitive |
|
|
|
cell line (H3122) |
hsa-miR-452-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (OVCAR3) |
hsa-miR-452-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (H460) |
hsa-miR-452-5p |
Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide/Methotrexate/Gemcitabine |
|
|
|
resistant |
|
|
|
cell line (Bats-72) |
|